Zika virus infection in the returning traveller: what every neurologist should know
- PMID: 29618586
- PMCID: PMC6204932
- DOI: 10.1136/practneurol-2017-001789
Zika virus infection in the returning traveller: what every neurologist should know
Abstract
Zika virus has been associated with a wide range of neurological complications. Neurologists in areas without current active transmission of the virus may be confronted with Zika-associated neurological disease, as a large number of returning travellers with Zika virus infection have been reported and the virus continues to spread to previously unaffected regions. This review provides an overview of Zika virus-associated neurological disease and aims to support neurologists who may encounter patients returning from endemic areas.
Keywords: Guillain-Barré syndrome; clinical neurology; neuroimmunology; neurovirology; zika virus.
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Conflict of interest statement
Competing interests: None declared.
Figures




Similar articles
-
Neurological Implications of Zika Virus Infection in Adults.J Infect Dis. 2017 Dec 16;216(suppl_10):S897-S905. doi: 10.1093/infdis/jix511. J Infect Dis. 2017. PMID: 29267923 Free PMC article. Review.
-
Surveillance report of Zika virus among Canadian travellers returning from the Americas.CMAJ. 2017 Mar 6;189(9):E334-E340. doi: 10.1503/cmaj.161241. CMAJ. 2017. PMID: 28280063 Free PMC article.
-
Neurological complications of Zika virus infection.Expert Rev Anti Infect Ther. 2018 May;16(5):399-410. doi: 10.1080/14787210.2018.1466702. Epub 2018 Apr 26. Expert Rev Anti Infect Ther. 2018. PMID: 29668332 Review.
-
Epidemiology and neurological complications of infection by the Zika virus: a new emerging neurotropic virus.Rev Neurol. 2016 Apr 1;62(7):317-28. Rev Neurol. 2016. PMID: 26988170 Review. English, Spanish.
-
Little risk of severe complications associated with Zika infection in New Zealand.N Z Med J. 2016 Aug 19;129(1440):108-13. N Z Med J. 2016. PMID: 27538044
Cited by
-
Effector CD8 T Cell-Dependent Zika Virus Control in the CNS: A Matter of Time and Numbers.Front Immunol. 2020 Aug 18;11:1977. doi: 10.3389/fimmu.2020.01977. eCollection 2020. Front Immunol. 2020. PMID: 32973802 Free PMC article.
-
HLA-A, HSPA5, IGFBP5 and PSMA2 Are Restriction Factors for Zika Virus Growth in Astrocytic Cells.Viruses. 2022 Dec 29;15(1):97. doi: 10.3390/v15010097. Viruses. 2022. PMID: 36680137 Free PMC article.
-
Knowledge of the Sexual Transmission of Zika Virus and Preventive Practices Against Zika Virus Among U.S. Travelers.J Community Health. 2019 Apr;44(2):377-386. doi: 10.1007/s10900-018-0594-x. J Community Health. 2019. PMID: 30478625
-
Novel Therapeutic Nutrients Molecules That Protect against Zika Virus Infection with a Special Note on Palmitoleate.Nutrients. 2022 Dec 27;15(1):124. doi: 10.3390/nu15010124. Nutrients. 2022. PMID: 36615782 Free PMC article. Review.
-
Incidence of Guillain-Barré Syndrome (GBS) in Latin America and the Caribbean before and during the 2015-2016 Zika virus epidemic: A systematic review and meta-analysis.PLoS Negl Trop Dis. 2019 Aug 26;13(8):e0007622. doi: 10.1371/journal.pntd.0007622. eCollection 2019 Aug. PLoS Negl Trop Dis. 2019. PMID: 31449532 Free PMC article.
References
-
- World Health Organization. Zika situation report 10 March 2017, 2017.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical